Smartleaf Asset Management’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.9K Hold
631
﹤0.01% 1958
2026
Q1
$16.7K Sell
631
-421
-40% -$10.8K ﹤0.01% 2060
2025
Q4
$22.8K Buy
+1,052
New +$20.8K ﹤0.01% 1958
2025
Q2
Sell
-186
Closed -$1.93K 2933
2025
Q1
$1.93K Hold
186
﹤0.01% 2479
2024
Q4
$2.13K Sell
186
-61
-25% -$721 ﹤0.01% 2519
2024
Q3
$2.83K Buy
247
+61
+33% +$694 ﹤0.01% 2363
2024
Q2
$1.97K Buy
+186
New +$2.04K ﹤0.01% 2235

Other funds holding ROIV

Smartleaf Asset Management's ROIV Position: Q2 2026 in Review

Smartleaf Asset Management held its Roivant Sciences (ROIV) position steady in Q2 2026 at 631 shares worth $21.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1958.

Smartleaf Asset Management first reported a position in ROIV in Q2 2024 and has held it in 7 quarters since. The position peaked at $22.8K in Q4 2025. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Smartleaf Asset Management held 631 shares of Roivant Sciences worth $21.9K as of Q2 2026.
  • Smartleaf Asset Management left its Roivant Sciences share count unchanged in Q2 2026.
  • Roivant Sciences made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #1958 holding.
  • Smartleaf Asset Management first reported a position in Roivant Sciences in Q2 2024 and has held it in 7 quarters since.
  • Smartleaf Asset Management's Roivant Sciences position peaked at $22.8K in Q4 2025.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.